Published in N Engl J Med on August 14, 2008
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation | NCT00007657
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.99
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Factors associated with racial differences in myocardial infarction outcomes. Ann Intern Med (2009) 2.54
Finding the courage to reconsider medical therapy for stable angina. N Engl J Med (2008) 2.30
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation (2010) 1.56
Strategies for dealing with missing data in clinical trials: from design to analysis. Yale J Biol Med (2013) 1.42
Impact of Multivessel Revascularization on Health Status Outcomes in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. J Am Coll Cardiol (2015) 1.40
Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One (2010) 1.32
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag (2010) 1.16
Decision-making process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer. J Gen Intern Med (2012) 1.12
Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma (2013) 1.06
Quality of life after late invasive therapy for occluded arteries. N Engl J Med (2009) 1.06
Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry. Circ Cardiovasc Qual Outcomes (2009) 1.04
Shared decision making in patients with stable coronary artery disease: PCI choice. PLoS One (2012) 1.01
Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA (2013) 1.01
Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention. Am J Cardiol (2012) 0.99
Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010. Glob Heart (2012) 0.99
Financial stress and outcomes after acute myocardial infarction. PLoS One (2012) 0.95
The rise of multiple imputation: a review of the reporting and implementation of the method in medical research. BMC Med Res Methodol (2015) 0.94
Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clin Res Cardiol (2013) 0.94
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR. Circ Cardiovasc Qual Outcomes (2012) 0.94
Percutaneous coronary intervention in the elderly. Nat Rev Cardiol (2010) 0.93
The pragmatist's guide to comparative effectiveness research. J Econ Perspect (2011) 0.92
Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization. Circ Cardiovasc Imaging (2012) 0.90
Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes. Clin Epidemiol (2015) 0.89
Health-related quality of life in premature acute coronary syndrome: does patient sex or gender really matter? J Am Heart Assoc (2014) 0.88
Debate over patient-centered care: percutaneous coronary intervention or coronary artery bypass grafting? Surg Today (2011) 0.87
Fractional flow reserve-guided percutaneous coronary intervention is not a valid concept. Circulation (2014) 0.86
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. J Nucl Cardiol (2013) 0.85
Incremental cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in patients at intermediate risk for coronary artery disease. Clin Res Cardiol (2014) 0.84
Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy. Clin Res Cardiol (2013) 0.84
The case for intervention bias in the practice of medicine. Yale J Biol Med (2013) 0.84
Depression as a Clinical Determinant of Dependence and Low Quality of Life in Elderly Patients with Cardiovascular Disease. Arq Bras Cardiol (2015) 0.84
Health-related quality-of-life after percutaneous coronary intervention in patients with UA/NSTEMI and STEMI: the Korean multicenter registry. J Korean Med Sci (2013) 0.83
Chronic total occlusion: To treat or not to treat. World J Cardiol (2014) 0.82
The potential value of integrated natriuretic peptide and echo-guided heart failure management. Cardiovasc Ultrasound (2014) 0.82
Health related quality of life and mental distress after PCI: restoring a state of equilibrium. Health Qual Life Outcomes (2013) 0.81
Clinical and scientific progress related to the interface between cardiology and psychology: lessons learned from 35 years of experience at the Thoraxcenter of the Erasmus Medical Center in Rotterdam. Neth Heart J (2011) 0.81
Five year prognosis in patients with angina identified in primary care: incident cohort study. BMJ (2009) 0.81
Patient-rated health status predicts prognosis following percutaneous coronary intervention with drug-eluting stenting. Qual Life Res (2010) 0.80
Clinical evidence versus patients' perception of coronary revascularization. Surg Today (2013) 0.80
Prognostic value of estimated functional capacity incremental to cardiac biomarkers in stable cardiac patients. J Am Heart Assoc (2014) 0.80
Self-reported health following percutaneous coronary intervention: results from a cohort followed for 3 years with multiple measurements. Clin Epidemiol (2014) 0.80
Quality of life (QOL) evaluation after acute coronary syndrome with simultaneous clopidogrel treatment. Arch Med Sci (2013) 0.79
Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options. Eur Heart J Acute Cardiovasc Care (2012) 0.79
Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification. Int J Cardiovasc Imaging (2010) 0.78
Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates. Circ Cardiovasc Imaging (2015) 0.78
Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT). Am Heart J (2011) 0.78
Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature. Clinicoecon Outcomes Res (2014) 0.78
Angina treatments and prevention of cardiac events: an appraisal of the evidence. Eur Heart J Suppl (2015) 0.78
Pharmacotherapy: Xanthine oxidase inhibition for relief of angina pectoris. Nat Rev Cardiol (2010) 0.78
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes (2013) 0.78
Danhong injection in the treatment of chronic stable angina: study protocol for a randomized controlled trial. Trials (2015) 0.77
Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study. J Am Heart Assoc (2016) 0.77
Stable angina pectoris: antianginal therapies and future directions. Nat Rev Cardiol (2011) 0.77
Trends in PCI volume after negative results from the COURAGE trial. Health Serv Res (2013) 0.76
Using COURAGE to treat angina. Medscape J Med (2008) 0.76
Drug-eluting coronary stents - focus on improved patient outcomes. Patient Relat Outcome Meas (2011) 0.76
A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina. Clin Med Insights Cardiol (2012) 0.76
The need to improve the appropriate use of coronary revascularization: challenges and opportunities. J Am Coll Cardiol (2012) 0.76
Experimental and early investigational drugs for angina pectoris. Expert Opin Investig Drugs (2016) 0.75
Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Mater Sociomed (2011) 0.75
Effects of Health Qigong Exercises on Relieving Symptoms of Parkinson's Disease. Evid Based Complement Alternat Med (2016) 0.75
Effects of a nurse-coordinated prevention programme on health-related quality of life and depression in patients with an acute coronary syndrome: results from the RESPONSE randomised controlled trial. BMC Cardiovasc Disord (2016) 0.75
Impact of coronary artery calcification on percutaneous coronary intervention and postprocedural complications. J Saudi Heart Assoc (2016) 0.75
Value-Based Hypothesis Testing for Cardiac Device Clinical Trials: A Pathway for Accelerated Reimbursement Decisions. Circ Cardiovasc Interv (2016) 0.75
Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina. Drugs R D (2013) 0.75
Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease. Clin Imaging (2017) 0.75
Quality of life with PCI versus medical therapy in stable coronary disease. N Engl J Med (2008) 0.75
Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study. J Am Heart Assoc (2016) 0.75
Chronic stable angina is associated with lower health-related quality of life: evidence from Chinese patients. PLoS One (2014) 0.75
Association between appropriateness of coronary revascularization and quality of life in patients with stable ischemic heart disease. BMC Cardiovasc Disord (2014) 0.75
The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes). J Am Coll Cardiol (2011) 0.75
Quality of life with PCI versus medical therapy in stable coronary disease. N Engl J Med (2008) 0.75
Assessing Quality of Life and Medical Care in Chronic Angina: An Internet Survey. Interact J Med Res (2016) 0.75
Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions. Am J Cardiovasc Dis (2013) 0.75
Assessing quality-of-life outcomes in cardiovascular clinical research. Nat Rev Cardiol (2016) 0.75
Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization. Angiology (2016) 0.75
Quality of life with PCI versus medical therapy in stable coronary disease. N Engl J Med (2008) 0.75
Estimation of years lived with disability due to noncommunicable diseases and injuries using a population-representative survey. PLoS One (2017) 0.75
The reversal of cardiology practices: interventions that were tried in vain. Cardiovasc Diagn Ther (2013) 0.75
Quality of life with PCI versus medical therapy in stable coronary disease. N Engl J Med (2008) 0.75
The role of CABG in the era of drug-eluting stents: a surgeon's viewpoint. Heart Asia (2010) 0.75
Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature. Front Cardiovasc Med (2016) 0.75
The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design. Catheter Cardiovasc Interv (2016) 0.75
Refining a brief decision aid in stable CAD: cognitive interviews. BMC Med Inform Decis Mak (2014) 0.75
Conduits for coronary bypass: strategies. Korean J Thorac Cardiovasc Surg (2013) 0.75
A multicentre randomized clinical trial on efficacy and safety of huxin formula in patients undergoing percutaneous coronary intervention. Evid Based Complement Alternat Med (2014) 0.75
Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease. Eur Heart J Qual Care Clin Outcomes (2016) 0.75
Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention. Adv Ther (2015) 0.75
Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina. Nat Clin Pract Cardiovasc Med (2008) 0.75
Almanac 2013: stable coronary artery disease. Wien Klin Wochenschr (2013) 0.75
Perceived Cognition after Percutaneous Coronary Intervention: Association with Quality of Life, Mood and Fatigue in the THORESCI Study. Int J Behav Med (2016) 0.75
The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? J Nucl Cardiol (2017) 0.75
A Personalized and Interactive Web-Based Health Care Innovation to Advance the Quality of Life and Care of Patients With Heart Failure (ACQUIRE-HF): A Mixed Methods Feasibility Study. JMIR Res Protoc (2017) 0.75
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
ZOOM! Zillions of oligos mapped. Bioinformatics (2008) 29.78
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem (2003) 15.88
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med (2011) 15.30
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20
HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe (2007) 7.34
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest (2009) 7.09
Probabilistic Boolean Networks: a rule-based uncertainty model for gene regulatory networks. Bioinformatics (2002) 6.90
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA (2011) 6.81
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81
Pten regulates neuronal arborization and social interaction in mice. Neuron (2006) 6.11
SCAN: SNP and copy number annotation. Bioinformatics (2009) 5.96
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA (2013) 5.19
Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA (2012) 5.17
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med (2010) 4.78
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
Defining obesity cut points in a multiethnic population. Circulation (2007) 4.42
Sequence and analysis of rice chromosome 4. Nature (2002) 4.39
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci U S A (2007) 4.35
Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
Concern Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation (2002) 4.16
Serum potassium levels and mortality in acute myocardial infarction. JAMA (2012) 4.09
Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest (2006) 4.06
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med (2008) 3.98
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol (2013) 3.90
Stargazin modulates AMPA receptor gating and trafficking by distinct domains. Nature (2005) 3.88
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell (2008) 3.87
Structure of the immature dengue virus at low pH primes proteolytic maturation. Science (2008) 3.86
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA (2006) 3.83
Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ (2011) 3.81
Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A (2008) 3.69
Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol (2008) 3.67
Conformational changes of the flavivirus E glycoprotein. Structure (2004) 3.66
Shell-isolated nanoparticle-enhanced Raman spectroscopy. Nature (2010) 3.64
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res (2004) 3.63
Structures of immature flavivirus particles. EMBO J (2003) 3.62
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Long-acting risperidone and oral antipsychotics in unstable schizophrenia. N Engl J Med (2011) 3.36
Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA (2010) 3.36
Genetic architecture of transcript-level variation in humans. Am J Hum Genet (2008) 3.36
Hospital-wide code rates and mortality before and after implementation of a rapid response team. JAMA (2008) 3.30